rig Search Results


86
Bico Inc s15
S15, supplied by Bico Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rig/s15/pm33683102__ic1c00030_si_001-63-0-17
Average 86 stars, based on 1 article reviews
s15 - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

90
Novus Biologicals rig i
Rig I, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rig/RIG-I+Antibody/10__1186_slash_1743___422x___10___286-171-16-18
Average 90 stars, based on 1 article reviews
rig i - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc pathway antibody sampler kit
Pathway Antibody Sampler Kit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rig/Rig-I+Pathway+Antibody+Sampler+Kit/pmc09871751-64-19-24
Average 94 stars, based on 1 article reviews
pathway antibody sampler kit - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc rig i
A mRNA expression levels of Irf9 were quantified by qPCR in brain samples from Rnaset2 −/− and Rnaset2 +/+ mice at 3, 6, 17, and 28 weeks of age. Values remain persistently increased, with mean fold changes between five and ten, showing no temporal peaks. Mean ± SEM with ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001, One-way ANOVA followed by Tukey’s multiple comparison test; n = 4 for 3 and 6 weeks, n = 5 for 17 and 28 weeks. Irf9: interferon regulatory factor 9 . B mRNA expression levels of Ddx58 were quantified by qPCR in brain samples from Rnaset2 −/− and Rnaset2 +/+ mice at 3, 6, 17, and 28 weeks of age. Values consistently show elevated levels, with mean fold changes ranging from five to ten, demonstrating no temporal peaks. Mean ± SEM with * = p < 0.05, ** = p < 0.01, ns not significant, One-way ANOVA followed by Tukey’s multiple comparison test; n = 4 for 3 and 6 weeks, n = 5 for 17 and 28 weeks. Ddx58: DEAD-Box Helicase 58 . C Western blot analysis of IRF9 in Rnaset2 −/− brains compared to Rnaset2 +/+ at 3 weeks of age. Blot intensity differences clearly depict increased IRF9 protein amounts. Likewise, densitometry quantification shows a substantial grey value difference of over 15,000 grey values between Rnaset2 −/− and Rnaset2 +/+ samples. Loading control: β-ACTIN. Mean ± SEM; n = 2 per group and time point. WT1-2: Rnaset2 +/+ , KO1-2: Rnaset2 −/− . IRF9: interferon regulatory factor 9. D Western blot analysis <t>of</t> <t>RIG-I</t> in Rnaset2 −/− brains compared to Rnaset2 −/− at 3 weeks of age. Differences in RIG-I grey value number are clearly visible between Rnaset2 −/− and Rnaset2 +/+ protein samples. Likewise, densitometry quantification demonstrates a 15,000-fold difference in grey values between Rnaset2 −/− and Rnaset2 +/+ protein samples. Loading control: β-ACTIN. Mean ± SEM; n = 2 per group and time point. WT1-2: Rnaset2 +/+ , KO1-2: Rnaset2 −/− . RIG-I: Retinoic acid-inducible gene I. E Western blot analysis of IRF9 protein amount at 6 weeks of age. Densitometry analysis of IRF9 signal intensities reveals a significant increase in IRF9 protein amounts in Rnaset2 −/− brain protein samples compared to samples from Rnaset2 +/+ (10-fold increase in Rnaset2 −/− , p < 0.001). Loading control: β-ACTIN. Mean ± SEM with *** = p < 0.001, Student’s t test; n = 4 per group and time point. WT1-4: Rnaset2 +/+ , KO1-4: Rnaset2 −/− . IRF9: interferon regulatory factor 9. F Western blot analysis of RIG-I at 6 weeks of age. Densitometry analysis of RIG-I signal intensities depicts a significant upregulation in RIG-I protein amounts in Rnaset2 −/− brains compared to Rnaset2 +/+ (nine-fold increase in Rnaset2 −/− , p < 0.001). Loading control: β-ACTIN. Mean ± SEM with *** = p < 0.001, Student’s t -test; n = 4 per group and time point. WT1-4: Rnaset2 +/+ , KO1-4: Rnaset2 −/− . RIG-I: Retinoic acid-inducible gene I. G Western blot analysis of IRF9 at 17 weeks of age. Densitometry quantification of IRF9 signal intensities reveals a significant increase in IRF9 in Rnaset2 −/− brains compared to Rnaset2 +/+ (ten-fold increase in Rnaset2 −/− , p < 0.001). Loading control: β-ACTIN. Mean ± SEM with *** = p < 0.001, Student’s t test; n = 4 per group and time point. WT1-4: Rnaset2 +/+ , KO1-4: Rnaset2 −/− . IRF9: interferon regulatory factor 9. H Western blot analysis of RIG-I at 17 weeks of age. In comparison to Rnaset2 +/+ brain samples, densitometry analysis of RIG-I signal intensities shows a significant increase in RIG-I protein amount in Rnaset2 −/− protein samples (10-fold increase in Rnaset2 −/− , p < 0.01). Loading control: β-ACTIN. Mean ± SEM with ** = p < 0.01, Student’s t test; n = 4 per group and time point. WT1-4: Rnaset2 +/+ , KO1-4: Rnaset2 −/− . RIG-I: Retinoic acid-inducible gene I. I Western blot analysis of IRF9 at 28 weeks of age. Blot intensities were measured using densitometry, and results show significantly higher levels of IRF9 protein in Rnaset2 −/− samples (ten-fold increase in Rnaset2 −/− , p < 0.05). Loading control: β-ACTIN. Mean ± SEM with * = p < 0.05, Student’s t test; n = 3 per group and time point. WT1-3: Rnaset2 +/+ , KO1-3: Rnaset2 −/− . IRF9: interferon regulatory factor 9. J Western blot analysis of RIG-I at 28 weeks of age. Blot densitometry shows significantly upregulated RIG-I protein amounts in Rnaset2 −/− brain samples (nine-fold increase in Rnaset2 −/− , p < 0.001). Loading control: β-ACTIN. Mean ± SEM with *** = p < 0.001, Student’s t test; n = 3 per group and time point. WT1-3: Rnaset2 +/+ , KO1-3: Rnaset2 −/− . RIG-I: Retinoic acid-inducible gene I.
Rig I, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rig/Rig-I+Rabbit+mAb/pmc12848040-28-0-4
Average 96 stars, based on 1 article reviews
rig i - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

93
Proteintech anti dkk3
A mRNA expression levels of Irf9 were quantified by qPCR in brain samples from Rnaset2 −/− and Rnaset2 +/+ mice at 3, 6, 17, and 28 weeks of age. Values remain persistently increased, with mean fold changes between five and ten, showing no temporal peaks. Mean ± SEM with ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001, One-way ANOVA followed by Tukey’s multiple comparison test; n = 4 for 3 and 6 weeks, n = 5 for 17 and 28 weeks. Irf9: interferon regulatory factor 9 . B mRNA expression levels of Ddx58 were quantified by qPCR in brain samples from Rnaset2 −/− and Rnaset2 +/+ mice at 3, 6, 17, and 28 weeks of age. Values consistently show elevated levels, with mean fold changes ranging from five to ten, demonstrating no temporal peaks. Mean ± SEM with * = p < 0.05, ** = p < 0.01, ns not significant, One-way ANOVA followed by Tukey’s multiple comparison test; n = 4 for 3 and 6 weeks, n = 5 for 17 and 28 weeks. Ddx58: DEAD-Box Helicase 58 . C Western blot analysis of IRF9 in Rnaset2 −/− brains compared to Rnaset2 +/+ at 3 weeks of age. Blot intensity differences clearly depict increased IRF9 protein amounts. Likewise, densitometry quantification shows a substantial grey value difference of over 15,000 grey values between Rnaset2 −/− and Rnaset2 +/+ samples. Loading control: β-ACTIN. Mean ± SEM; n = 2 per group and time point. WT1-2: Rnaset2 +/+ , KO1-2: Rnaset2 −/− . IRF9: interferon regulatory factor 9. D Western blot analysis <t>of</t> <t>RIG-I</t> in Rnaset2 −/− brains compared to Rnaset2 −/− at 3 weeks of age. Differences in RIG-I grey value number are clearly visible between Rnaset2 −/− and Rnaset2 +/+ protein samples. Likewise, densitometry quantification demonstrates a 15,000-fold difference in grey values between Rnaset2 −/− and Rnaset2 +/+ protein samples. Loading control: β-ACTIN. Mean ± SEM; n = 2 per group and time point. WT1-2: Rnaset2 +/+ , KO1-2: Rnaset2 −/− . RIG-I: Retinoic acid-inducible gene I. E Western blot analysis of IRF9 protein amount at 6 weeks of age. Densitometry analysis of IRF9 signal intensities reveals a significant increase in IRF9 protein amounts in Rnaset2 −/− brain protein samples compared to samples from Rnaset2 +/+ (10-fold increase in Rnaset2 −/− , p < 0.001). Loading control: β-ACTIN. Mean ± SEM with *** = p < 0.001, Student’s t test; n = 4 per group and time point. WT1-4: Rnaset2 +/+ , KO1-4: Rnaset2 −/− . IRF9: interferon regulatory factor 9. F Western blot analysis of RIG-I at 6 weeks of age. Densitometry analysis of RIG-I signal intensities depicts a significant upregulation in RIG-I protein amounts in Rnaset2 −/− brains compared to Rnaset2 +/+ (nine-fold increase in Rnaset2 −/− , p < 0.001). Loading control: β-ACTIN. Mean ± SEM with *** = p < 0.001, Student’s t -test; n = 4 per group and time point. WT1-4: Rnaset2 +/+ , KO1-4: Rnaset2 −/− . RIG-I: Retinoic acid-inducible gene I. G Western blot analysis of IRF9 at 17 weeks of age. Densitometry quantification of IRF9 signal intensities reveals a significant increase in IRF9 in Rnaset2 −/− brains compared to Rnaset2 +/+ (ten-fold increase in Rnaset2 −/− , p < 0.001). Loading control: β-ACTIN. Mean ± SEM with *** = p < 0.001, Student’s t test; n = 4 per group and time point. WT1-4: Rnaset2 +/+ , KO1-4: Rnaset2 −/− . IRF9: interferon regulatory factor 9. H Western blot analysis of RIG-I at 17 weeks of age. In comparison to Rnaset2 +/+ brain samples, densitometry analysis of RIG-I signal intensities shows a significant increase in RIG-I protein amount in Rnaset2 −/− protein samples (10-fold increase in Rnaset2 −/− , p < 0.01). Loading control: β-ACTIN. Mean ± SEM with ** = p < 0.01, Student’s t test; n = 4 per group and time point. WT1-4: Rnaset2 +/+ , KO1-4: Rnaset2 −/− . RIG-I: Retinoic acid-inducible gene I. I Western blot analysis of IRF9 at 28 weeks of age. Blot intensities were measured using densitometry, and results show significantly higher levels of IRF9 protein in Rnaset2 −/− samples (ten-fold increase in Rnaset2 −/− , p < 0.05). Loading control: β-ACTIN. Mean ± SEM with * = p < 0.05, Student’s t test; n = 3 per group and time point. WT1-3: Rnaset2 +/+ , KO1-3: Rnaset2 −/− . IRF9: interferon regulatory factor 9. J Western blot analysis of RIG-I at 28 weeks of age. Blot densitometry shows significantly upregulated RIG-I protein amounts in Rnaset2 −/− brain samples (nine-fold increase in Rnaset2 −/− , p < 0.001). Loading control: β-ACTIN. Mean ± SEM with *** = p < 0.001, Student’s t test; n = 3 per group and time point. WT1-3: Rnaset2 +/+ , KO1-3: Rnaset2 −/− . RIG-I: Retinoic acid-inducible gene I.
Anti Dkk3, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rig/DKK3+Antibody/bio_rxiv__2024__04__10__588813-195-36-37
Average 93 stars, based on 1 article reviews
anti dkk3 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

95
Proteintech anti rig i ddx58
A mRNA expression levels of Irf9 were quantified by qPCR in brain samples from Rnaset2 −/− and Rnaset2 +/+ mice at 3, 6, 17, and 28 weeks of age. Values remain persistently increased, with mean fold changes between five and ten, showing no temporal peaks. Mean ± SEM with ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001, One-way ANOVA followed by Tukey’s multiple comparison test; n = 4 for 3 and 6 weeks, n = 5 for 17 and 28 weeks. Irf9: interferon regulatory factor 9 . B mRNA expression levels of Ddx58 were quantified by qPCR in brain samples from Rnaset2 −/− and Rnaset2 +/+ mice at 3, 6, 17, and 28 weeks of age. Values consistently show elevated levels, with mean fold changes ranging from five to ten, demonstrating no temporal peaks. Mean ± SEM with * = p < 0.05, ** = p < 0.01, ns not significant, One-way ANOVA followed by Tukey’s multiple comparison test; n = 4 for 3 and 6 weeks, n = 5 for 17 and 28 weeks. Ddx58: DEAD-Box Helicase 58 . C Western blot analysis of IRF9 in Rnaset2 −/− brains compared to Rnaset2 +/+ at 3 weeks of age. Blot intensity differences clearly depict increased IRF9 protein amounts. Likewise, densitometry quantification shows a substantial grey value difference of over 15,000 grey values between Rnaset2 −/− and Rnaset2 +/+ samples. Loading control: β-ACTIN. Mean ± SEM; n = 2 per group and time point. WT1-2: Rnaset2 +/+ , KO1-2: Rnaset2 −/− . IRF9: interferon regulatory factor 9. D Western blot analysis <t>of</t> <t>RIG-I</t> in Rnaset2 −/− brains compared to Rnaset2 −/− at 3 weeks of age. Differences in RIG-I grey value number are clearly visible between Rnaset2 −/− and Rnaset2 +/+ protein samples. Likewise, densitometry quantification demonstrates a 15,000-fold difference in grey values between Rnaset2 −/− and Rnaset2 +/+ protein samples. Loading control: β-ACTIN. Mean ± SEM; n = 2 per group and time point. WT1-2: Rnaset2 +/+ , KO1-2: Rnaset2 −/− . RIG-I: Retinoic acid-inducible gene I. E Western blot analysis of IRF9 protein amount at 6 weeks of age. Densitometry analysis of IRF9 signal intensities reveals a significant increase in IRF9 protein amounts in Rnaset2 −/− brain protein samples compared to samples from Rnaset2 +/+ (10-fold increase in Rnaset2 −/− , p < 0.001). Loading control: β-ACTIN. Mean ± SEM with *** = p < 0.001, Student’s t test; n = 4 per group and time point. WT1-4: Rnaset2 +/+ , KO1-4: Rnaset2 −/− . IRF9: interferon regulatory factor 9. F Western blot analysis of RIG-I at 6 weeks of age. Densitometry analysis of RIG-I signal intensities depicts a significant upregulation in RIG-I protein amounts in Rnaset2 −/− brains compared to Rnaset2 +/+ (nine-fold increase in Rnaset2 −/− , p < 0.001). Loading control: β-ACTIN. Mean ± SEM with *** = p < 0.001, Student’s t -test; n = 4 per group and time point. WT1-4: Rnaset2 +/+ , KO1-4: Rnaset2 −/− . RIG-I: Retinoic acid-inducible gene I. G Western blot analysis of IRF9 at 17 weeks of age. Densitometry quantification of IRF9 signal intensities reveals a significant increase in IRF9 in Rnaset2 −/− brains compared to Rnaset2 +/+ (ten-fold increase in Rnaset2 −/− , p < 0.001). Loading control: β-ACTIN. Mean ± SEM with *** = p < 0.001, Student’s t test; n = 4 per group and time point. WT1-4: Rnaset2 +/+ , KO1-4: Rnaset2 −/− . IRF9: interferon regulatory factor 9. H Western blot analysis of RIG-I at 17 weeks of age. In comparison to Rnaset2 +/+ brain samples, densitometry analysis of RIG-I signal intensities shows a significant increase in RIG-I protein amount in Rnaset2 −/− protein samples (10-fold increase in Rnaset2 −/− , p < 0.01). Loading control: β-ACTIN. Mean ± SEM with ** = p < 0.01, Student’s t test; n = 4 per group and time point. WT1-4: Rnaset2 +/+ , KO1-4: Rnaset2 −/− . RIG-I: Retinoic acid-inducible gene I. I Western blot analysis of IRF9 at 28 weeks of age. Blot intensities were measured using densitometry, and results show significantly higher levels of IRF9 protein in Rnaset2 −/− samples (ten-fold increase in Rnaset2 −/− , p < 0.05). Loading control: β-ACTIN. Mean ± SEM with * = p < 0.05, Student’s t test; n = 3 per group and time point. WT1-3: Rnaset2 +/+ , KO1-3: Rnaset2 −/− . IRF9: interferon regulatory factor 9. J Western blot analysis of RIG-I at 28 weeks of age. Blot densitometry shows significantly upregulated RIG-I protein amounts in Rnaset2 −/− brain samples (nine-fold increase in Rnaset2 −/− , p < 0.001). Loading control: β-ACTIN. Mean ± SEM with *** = p < 0.001, Student’s t test; n = 3 per group and time point. WT1-3: Rnaset2 +/+ , KO1-3: Rnaset2 −/− . RIG-I: Retinoic acid-inducible gene I.
Anti Rig I Ddx58, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rig/DDX58+Antibody/pmc12724194-186-125-127
Average 95 stars, based on 1 article reviews
anti rig i ddx58 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

94
Proteintech anti ifit3
A mRNA expression levels of Irf9 were quantified by qPCR in brain samples from Rnaset2 −/− and Rnaset2 +/+ mice at 3, 6, 17, and 28 weeks of age. Values remain persistently increased, with mean fold changes between five and ten, showing no temporal peaks. Mean ± SEM with ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001, One-way ANOVA followed by Tukey’s multiple comparison test; n = 4 for 3 and 6 weeks, n = 5 for 17 and 28 weeks. Irf9: interferon regulatory factor 9 . B mRNA expression levels of Ddx58 were quantified by qPCR in brain samples from Rnaset2 −/− and Rnaset2 +/+ mice at 3, 6, 17, and 28 weeks of age. Values consistently show elevated levels, with mean fold changes ranging from five to ten, demonstrating no temporal peaks. Mean ± SEM with * = p < 0.05, ** = p < 0.01, ns not significant, One-way ANOVA followed by Tukey’s multiple comparison test; n = 4 for 3 and 6 weeks, n = 5 for 17 and 28 weeks. Ddx58: DEAD-Box Helicase 58 . C Western blot analysis of IRF9 in Rnaset2 −/− brains compared to Rnaset2 +/+ at 3 weeks of age. Blot intensity differences clearly depict increased IRF9 protein amounts. Likewise, densitometry quantification shows a substantial grey value difference of over 15,000 grey values between Rnaset2 −/− and Rnaset2 +/+ samples. Loading control: β-ACTIN. Mean ± SEM; n = 2 per group and time point. WT1-2: Rnaset2 +/+ , KO1-2: Rnaset2 −/− . IRF9: interferon regulatory factor 9. D Western blot analysis <t>of</t> <t>RIG-I</t> in Rnaset2 −/− brains compared to Rnaset2 −/− at 3 weeks of age. Differences in RIG-I grey value number are clearly visible between Rnaset2 −/− and Rnaset2 +/+ protein samples. Likewise, densitometry quantification demonstrates a 15,000-fold difference in grey values between Rnaset2 −/− and Rnaset2 +/+ protein samples. Loading control: β-ACTIN. Mean ± SEM; n = 2 per group and time point. WT1-2: Rnaset2 +/+ , KO1-2: Rnaset2 −/− . RIG-I: Retinoic acid-inducible gene I. E Western blot analysis of IRF9 protein amount at 6 weeks of age. Densitometry analysis of IRF9 signal intensities reveals a significant increase in IRF9 protein amounts in Rnaset2 −/− brain protein samples compared to samples from Rnaset2 +/+ (10-fold increase in Rnaset2 −/− , p < 0.001). Loading control: β-ACTIN. Mean ± SEM with *** = p < 0.001, Student’s t test; n = 4 per group and time point. WT1-4: Rnaset2 +/+ , KO1-4: Rnaset2 −/− . IRF9: interferon regulatory factor 9. F Western blot analysis of RIG-I at 6 weeks of age. Densitometry analysis of RIG-I signal intensities depicts a significant upregulation in RIG-I protein amounts in Rnaset2 −/− brains compared to Rnaset2 +/+ (nine-fold increase in Rnaset2 −/− , p < 0.001). Loading control: β-ACTIN. Mean ± SEM with *** = p < 0.001, Student’s t -test; n = 4 per group and time point. WT1-4: Rnaset2 +/+ , KO1-4: Rnaset2 −/− . RIG-I: Retinoic acid-inducible gene I. G Western blot analysis of IRF9 at 17 weeks of age. Densitometry quantification of IRF9 signal intensities reveals a significant increase in IRF9 in Rnaset2 −/− brains compared to Rnaset2 +/+ (ten-fold increase in Rnaset2 −/− , p < 0.001). Loading control: β-ACTIN. Mean ± SEM with *** = p < 0.001, Student’s t test; n = 4 per group and time point. WT1-4: Rnaset2 +/+ , KO1-4: Rnaset2 −/− . IRF9: interferon regulatory factor 9. H Western blot analysis of RIG-I at 17 weeks of age. In comparison to Rnaset2 +/+ brain samples, densitometry analysis of RIG-I signal intensities shows a significant increase in RIG-I protein amount in Rnaset2 −/− protein samples (10-fold increase in Rnaset2 −/− , p < 0.01). Loading control: β-ACTIN. Mean ± SEM with ** = p < 0.01, Student’s t test; n = 4 per group and time point. WT1-4: Rnaset2 +/+ , KO1-4: Rnaset2 −/− . RIG-I: Retinoic acid-inducible gene I. I Western blot analysis of IRF9 at 28 weeks of age. Blot intensities were measured using densitometry, and results show significantly higher levels of IRF9 protein in Rnaset2 −/− samples (ten-fold increase in Rnaset2 −/− , p < 0.05). Loading control: β-ACTIN. Mean ± SEM with * = p < 0.05, Student’s t test; n = 3 per group and time point. WT1-3: Rnaset2 +/+ , KO1-3: Rnaset2 −/− . IRF9: interferon regulatory factor 9. J Western blot analysis of RIG-I at 28 weeks of age. Blot densitometry shows significantly upregulated RIG-I protein amounts in Rnaset2 −/− brain samples (nine-fold increase in Rnaset2 −/− , p < 0.001). Loading control: β-ACTIN. Mean ± SEM with *** = p < 0.001, Student’s t test; n = 3 per group and time point. WT1-3: Rnaset2 +/+ , KO1-3: Rnaset2 −/− . RIG-I: Retinoic acid-inducible gene I.
Anti Ifit3, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rig/IFIT3+Antibody/10__1128_slash_jvi__01672___16-38-15-26
Average 94 stars, based on 1 article reviews
anti ifit3 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

92
Proteintech rabbit polyclonal anti rps15

Rabbit Polyclonal Anti Rps15, supplied by Proteintech, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rig/RPS15+Antibody/pmc10140000-32-0-4
Average 92 stars, based on 1 article reviews
rabbit polyclonal anti rps15 - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

94
Proteintech ube2l6 antibody

Ube2l6 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rig/UBE2L6+Antibody/pm41577004-74-1-7
Average 94 stars, based on 1 article reviews
ube2l6 antibody - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

91
ProSci Incorporated rabbit anti rig i

Rabbit Anti Rig I, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rig/RIG-1+Antibody/pmc03047619-428-53-56
Average 91 stars, based on 1 article reviews
rabbit anti rig i - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

94
Proteintech immunodetection rabbit anti lgp2

Immunodetection Rabbit Anti Lgp2, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rig/LGP2+Antibody/pm41171864-61-11-19
Average 94 stars, based on 1 article reviews
immunodetection rabbit anti lgp2 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

95
Santa Cruz Biotechnology mouse monoclonal αrig

Mouse Monoclonal αrig, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rig/RIG-I+Antibody/bio_rxiv__2023__04__20__537741-138-35-40
Average 95 stars, based on 1 article reviews
mouse monoclonal αrig - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

Image Search Results


A mRNA expression levels of Irf9 were quantified by qPCR in brain samples from Rnaset2 −/− and Rnaset2 +/+ mice at 3, 6, 17, and 28 weeks of age. Values remain persistently increased, with mean fold changes between five and ten, showing no temporal peaks. Mean ± SEM with ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001, One-way ANOVA followed by Tukey’s multiple comparison test; n = 4 for 3 and 6 weeks, n = 5 for 17 and 28 weeks. Irf9: interferon regulatory factor 9 . B mRNA expression levels of Ddx58 were quantified by qPCR in brain samples from Rnaset2 −/− and Rnaset2 +/+ mice at 3, 6, 17, and 28 weeks of age. Values consistently show elevated levels, with mean fold changes ranging from five to ten, demonstrating no temporal peaks. Mean ± SEM with * = p < 0.05, ** = p < 0.01, ns not significant, One-way ANOVA followed by Tukey’s multiple comparison test; n = 4 for 3 and 6 weeks, n = 5 for 17 and 28 weeks. Ddx58: DEAD-Box Helicase 58 . C Western blot analysis of IRF9 in Rnaset2 −/− brains compared to Rnaset2 +/+ at 3 weeks of age. Blot intensity differences clearly depict increased IRF9 protein amounts. Likewise, densitometry quantification shows a substantial grey value difference of over 15,000 grey values between Rnaset2 −/− and Rnaset2 +/+ samples. Loading control: β-ACTIN. Mean ± SEM; n = 2 per group and time point. WT1-2: Rnaset2 +/+ , KO1-2: Rnaset2 −/− . IRF9: interferon regulatory factor 9. D Western blot analysis of RIG-I in Rnaset2 −/− brains compared to Rnaset2 −/− at 3 weeks of age. Differences in RIG-I grey value number are clearly visible between Rnaset2 −/− and Rnaset2 +/+ protein samples. Likewise, densitometry quantification demonstrates a 15,000-fold difference in grey values between Rnaset2 −/− and Rnaset2 +/+ protein samples. Loading control: β-ACTIN. Mean ± SEM; n = 2 per group and time point. WT1-2: Rnaset2 +/+ , KO1-2: Rnaset2 −/− . RIG-I: Retinoic acid-inducible gene I. E Western blot analysis of IRF9 protein amount at 6 weeks of age. Densitometry analysis of IRF9 signal intensities reveals a significant increase in IRF9 protein amounts in Rnaset2 −/− brain protein samples compared to samples from Rnaset2 +/+ (10-fold increase in Rnaset2 −/− , p < 0.001). Loading control: β-ACTIN. Mean ± SEM with *** = p < 0.001, Student’s t test; n = 4 per group and time point. WT1-4: Rnaset2 +/+ , KO1-4: Rnaset2 −/− . IRF9: interferon regulatory factor 9. F Western blot analysis of RIG-I at 6 weeks of age. Densitometry analysis of RIG-I signal intensities depicts a significant upregulation in RIG-I protein amounts in Rnaset2 −/− brains compared to Rnaset2 +/+ (nine-fold increase in Rnaset2 −/− , p < 0.001). Loading control: β-ACTIN. Mean ± SEM with *** = p < 0.001, Student’s t -test; n = 4 per group and time point. WT1-4: Rnaset2 +/+ , KO1-4: Rnaset2 −/− . RIG-I: Retinoic acid-inducible gene I. G Western blot analysis of IRF9 at 17 weeks of age. Densitometry quantification of IRF9 signal intensities reveals a significant increase in IRF9 in Rnaset2 −/− brains compared to Rnaset2 +/+ (ten-fold increase in Rnaset2 −/− , p < 0.001). Loading control: β-ACTIN. Mean ± SEM with *** = p < 0.001, Student’s t test; n = 4 per group and time point. WT1-4: Rnaset2 +/+ , KO1-4: Rnaset2 −/− . IRF9: interferon regulatory factor 9. H Western blot analysis of RIG-I at 17 weeks of age. In comparison to Rnaset2 +/+ brain samples, densitometry analysis of RIG-I signal intensities shows a significant increase in RIG-I protein amount in Rnaset2 −/− protein samples (10-fold increase in Rnaset2 −/− , p < 0.01). Loading control: β-ACTIN. Mean ± SEM with ** = p < 0.01, Student’s t test; n = 4 per group and time point. WT1-4: Rnaset2 +/+ , KO1-4: Rnaset2 −/− . RIG-I: Retinoic acid-inducible gene I. I Western blot analysis of IRF9 at 28 weeks of age. Blot intensities were measured using densitometry, and results show significantly higher levels of IRF9 protein in Rnaset2 −/− samples (ten-fold increase in Rnaset2 −/− , p < 0.05). Loading control: β-ACTIN. Mean ± SEM with * = p < 0.05, Student’s t test; n = 3 per group and time point. WT1-3: Rnaset2 +/+ , KO1-3: Rnaset2 −/− . IRF9: interferon regulatory factor 9. J Western blot analysis of RIG-I at 28 weeks of age. Blot densitometry shows significantly upregulated RIG-I protein amounts in Rnaset2 −/− brain samples (nine-fold increase in Rnaset2 −/− , p < 0.001). Loading control: β-ACTIN. Mean ± SEM with *** = p < 0.001, Student’s t test; n = 3 per group and time point. WT1-3: Rnaset2 +/+ , KO1-3: Rnaset2 −/− . RIG-I: Retinoic acid-inducible gene I.

Journal: Cell Death & Disease

Article Title: Unlocking microglia pyroptosis in a model of type I interferon-driven neuroinflammation: lessons from Rnaset2 −/− mice

doi: 10.1038/s41419-025-08350-0

Figure Lengend Snippet: A mRNA expression levels of Irf9 were quantified by qPCR in brain samples from Rnaset2 −/− and Rnaset2 +/+ mice at 3, 6, 17, and 28 weeks of age. Values remain persistently increased, with mean fold changes between five and ten, showing no temporal peaks. Mean ± SEM with ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001, One-way ANOVA followed by Tukey’s multiple comparison test; n = 4 for 3 and 6 weeks, n = 5 for 17 and 28 weeks. Irf9: interferon regulatory factor 9 . B mRNA expression levels of Ddx58 were quantified by qPCR in brain samples from Rnaset2 −/− and Rnaset2 +/+ mice at 3, 6, 17, and 28 weeks of age. Values consistently show elevated levels, with mean fold changes ranging from five to ten, demonstrating no temporal peaks. Mean ± SEM with * = p < 0.05, ** = p < 0.01, ns not significant, One-way ANOVA followed by Tukey’s multiple comparison test; n = 4 for 3 and 6 weeks, n = 5 for 17 and 28 weeks. Ddx58: DEAD-Box Helicase 58 . C Western blot analysis of IRF9 in Rnaset2 −/− brains compared to Rnaset2 +/+ at 3 weeks of age. Blot intensity differences clearly depict increased IRF9 protein amounts. Likewise, densitometry quantification shows a substantial grey value difference of over 15,000 grey values between Rnaset2 −/− and Rnaset2 +/+ samples. Loading control: β-ACTIN. Mean ± SEM; n = 2 per group and time point. WT1-2: Rnaset2 +/+ , KO1-2: Rnaset2 −/− . IRF9: interferon regulatory factor 9. D Western blot analysis of RIG-I in Rnaset2 −/− brains compared to Rnaset2 −/− at 3 weeks of age. Differences in RIG-I grey value number are clearly visible between Rnaset2 −/− and Rnaset2 +/+ protein samples. Likewise, densitometry quantification demonstrates a 15,000-fold difference in grey values between Rnaset2 −/− and Rnaset2 +/+ protein samples. Loading control: β-ACTIN. Mean ± SEM; n = 2 per group and time point. WT1-2: Rnaset2 +/+ , KO1-2: Rnaset2 −/− . RIG-I: Retinoic acid-inducible gene I. E Western blot analysis of IRF9 protein amount at 6 weeks of age. Densitometry analysis of IRF9 signal intensities reveals a significant increase in IRF9 protein amounts in Rnaset2 −/− brain protein samples compared to samples from Rnaset2 +/+ (10-fold increase in Rnaset2 −/− , p < 0.001). Loading control: β-ACTIN. Mean ± SEM with *** = p < 0.001, Student’s t test; n = 4 per group and time point. WT1-4: Rnaset2 +/+ , KO1-4: Rnaset2 −/− . IRF9: interferon regulatory factor 9. F Western blot analysis of RIG-I at 6 weeks of age. Densitometry analysis of RIG-I signal intensities depicts a significant upregulation in RIG-I protein amounts in Rnaset2 −/− brains compared to Rnaset2 +/+ (nine-fold increase in Rnaset2 −/− , p < 0.001). Loading control: β-ACTIN. Mean ± SEM with *** = p < 0.001, Student’s t -test; n = 4 per group and time point. WT1-4: Rnaset2 +/+ , KO1-4: Rnaset2 −/− . RIG-I: Retinoic acid-inducible gene I. G Western blot analysis of IRF9 at 17 weeks of age. Densitometry quantification of IRF9 signal intensities reveals a significant increase in IRF9 in Rnaset2 −/− brains compared to Rnaset2 +/+ (ten-fold increase in Rnaset2 −/− , p < 0.001). Loading control: β-ACTIN. Mean ± SEM with *** = p < 0.001, Student’s t test; n = 4 per group and time point. WT1-4: Rnaset2 +/+ , KO1-4: Rnaset2 −/− . IRF9: interferon regulatory factor 9. H Western blot analysis of RIG-I at 17 weeks of age. In comparison to Rnaset2 +/+ brain samples, densitometry analysis of RIG-I signal intensities shows a significant increase in RIG-I protein amount in Rnaset2 −/− protein samples (10-fold increase in Rnaset2 −/− , p < 0.01). Loading control: β-ACTIN. Mean ± SEM with ** = p < 0.01, Student’s t test; n = 4 per group and time point. WT1-4: Rnaset2 +/+ , KO1-4: Rnaset2 −/− . RIG-I: Retinoic acid-inducible gene I. I Western blot analysis of IRF9 at 28 weeks of age. Blot intensities were measured using densitometry, and results show significantly higher levels of IRF9 protein in Rnaset2 −/− samples (ten-fold increase in Rnaset2 −/− , p < 0.05). Loading control: β-ACTIN. Mean ± SEM with * = p < 0.05, Student’s t test; n = 3 per group and time point. WT1-3: Rnaset2 +/+ , KO1-3: Rnaset2 −/− . IRF9: interferon regulatory factor 9. J Western blot analysis of RIG-I at 28 weeks of age. Blot densitometry shows significantly upregulated RIG-I protein amounts in Rnaset2 −/− brain samples (nine-fold increase in Rnaset2 −/− , p < 0.001). Loading control: β-ACTIN. Mean ± SEM with *** = p < 0.001, Student’s t test; n = 3 per group and time point. WT1-3: Rnaset2 +/+ , KO1-3: Rnaset2 −/− . RIG-I: Retinoic acid-inducible gene I.

Article Snippet: RIG-I , 3743 , Cell Signaling, Danvers, MA, USA , Western Blot , 1:1000.

Techniques: Expressing, Comparison, Western Blot, Control

Journal: iScience

Article Title: TIAR and FMRP shape pro-survival nascent proteome of leukemia cells in the bone marrow microenvironment

doi: 10.1016/j.isci.2023.106543

Figure Lengend Snippet:

Article Snippet: Rabbit polyclonal anti-RPS15 , Proteintech , Cat#14957-1-AP.

Techniques: Purification, Virus, shRNA, Control, Transduction, Knockdown, Recombinant, Extraction, Reporter Assay, Lysis, Plasmid Preparation, Software